Last edition
News about "WuXi XDC Cayman Inc."
WuXi XDC Secures GMP Release of Newly Launched DP3 Facility at Wuxi Site
WuXi XDC Cayman Inc. has announced the GMP release of its high-capacity DP3 facility at the Wuxi site, expanding its bioconjugate drug product manufacturing to 15 million vials annually.
WuXi XDC Cayman Inc. | 06/08/2025 | By Mrinmoy Dey | 118
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members